Tumor suppressor gene
Top View
- Gain-Of-Function Mutations in the Tumor Suppressor Gene P53
- Oncogene Or Tumor Suppressor Gene
- Alterations of the P16 Gene in Head and Neck Cancer: Frequency and Association with P53, PRAD-1 and HPV
- Tumor Suppressors Having Oncogenic Functions: the Double Agents
- Ras Mutations in Cancer
- Jun Dimerization Protein 2 Controls Senescence and Differentiation Via Regulating Histone Modification
- Abnormalities of Tumor Suppressor Gene P16 in Pancreatic Carcinoma: Immunohistochemical and Genetic findings Compared with Clinicopathological Parameters
- PTEN Augments Staurosporine-Induced Apoptosis in PTEN-Null Ishikawa Cells by Downregulating PI3K/Akt Signaling Pathway
- Mechanisms of Inactivation of P14arf, P15ink4b, and P16ink4a Genes in Human Esophageal Squamous Cell Carcinoma1
- Mutation Analysis of Tumor Suppressor Gene PTEN in Patients with Gastric Carcinomas and Its Impact on PI3K/AKT Pathway
- Oncogene Activation and Tumor Suppressor Gene Inactivation During Multistage Mouse Skin Carcinogenesis1
- The Long and Winding Road to Rational Treatment of Cancer Associated with LKB1/AMPK/TSC/Mtorc1 Signaling
- BRCA1 As a Tumor Suppressor Linked to the Regulation of Epigenetic States: Keeping Oncomirs Under Control
- Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
- Histone Chaperone Jun Dimerization Protein 2 (Jdp2): Role in Cellular Senescence and Aging
- Understanding BRCA2 Function As a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses
- Homozygous Deletions of the Ink4a/ARF Locus in Renal Cell Cancer
- Mouse Models in Tumor Suppression